Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

NCT05502458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Desflurane Adverse Reaction
Propofol Adverse Reaction
Circulating Tumor Cells

Interventions

DRUG: Desﬂurane
DRUG: Propofol

Sponsor

Zhejiang Cancer Hospital